Literature DB >> 23093736

Point-of-care tests for the diagnosis of Neisseria gonorrhoeae infection: a systematic review of operational and performance characteristics.

Lucy Alexandra Watchirs Smith1, Richard Hillman, James Ward, David M Whiley, Louise Causer, Steven Skov, Basil Donovan, John Kaldor, Rebecca Guy.   

Abstract

OBJECTIVES: Systematic review of the performance and operational characteristics of point-of-care (POC) tests for the diagnosis of Neisseria gonorrhoeae.
METHODS: We searched PubMed and Embase until August 2010 using variations of the terms: 'rapid test', 'Neisseria gonorrhoeae' and 'evaluation'.
RESULTS: We identified 100 papers, 14 studies were included; nine evaluated leucocyte esterase (LE) dipsticks and three immunochromatographic strips, and two clinical audits of microscopy were identified. Of the field evaluations the gold standard was nucleic acid amplification technology in six studies and bacterial culture in the other six. In four studies, 50% or more of the patients were symptomatic. The median sensitivity of LE dipsticks was 71% (range 23-85%), median specificity was 70% (33-99%), median positive predictive value (PPV) was 19% (5-40%) and median negative predictive value (NPV) was 95% (56-99%). One LE study found a sensitivity of 23% overall, increasing to 75% in symptomatic women. LE dipsticks mostly involved three steps and took under 2 min. The median sensitivity of immunochromatographic tests (ICT) was 70% (60-94%), median specificity was 96% (89-97%), median PPV was 56% (55-97%) and median NPV was 93% (92-99%). Immunochromatic strips involved five to seven steps and took 15-30 min. Specificity of microscopy ranged from 38% to 89%.
CONCLUSIONS: ICT and LE tests had similar sensitivities, but sensitivity results may be overestimated as largely symptomatic patients were included in some studies. ICT had a higher specificity in women than LE tests. The findings highlight the need for improved POC tests for diagnosis of N gonorrhoeae and more standardised evaluations.

Entities:  

Keywords:  Diagnosis; Gonorrhoea; Systematic Reviews; Testing

Mesh:

Substances:

Year:  2012        PMID: 23093736     DOI: 10.1136/sextrans-2012-050656

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  13 in total

1.  Inflammatory cytokine biomarkers to identify women with asymptomatic sexually transmitted infections and bacterial vaginosis who are at high risk of HIV infection.

Authors:  Lindi Masson; Kelly B Arnold; Francesca Little; Koleka Mlisana; David A Lewis; Nonhlanhla Mkhize; Hoyam Gamieldien; Sinaye Ngcapu; Leigh Johnson; Douglas A Lauffenburger; Quarraisha Abdool Karim; Salim S Abdool Karim; Jo-Ann S Passmore
Journal:  Sex Transm Infect       Date:  2015-10-28       Impact factor: 3.519

2.  Point-by-Point Progress: Gonorrhea Point of Care Tests.

Authors:  Charlotte A Gaydos; Johan H Melendez
Journal:  Expert Rev Mol Diagn       Date:  2020-06-30       Impact factor: 5.225

3.  Multiplex Real-Time PCR Assay for Simultaneous Identification of Neisseria gonorrhoeae and Its Ciprofloxacin Susceptibility Status.

Authors:  Sumudu R Perera; Nurul H Khan; Irene Martin; Ali Taheri; Rajinder P Parti; Paul N Levett; Greg B Horsman; Anthony Kusalik; Jo-Anne R Dillon
Journal:  J Clin Microbiol       Date:  2017-08-16       Impact factor: 5.948

Review 4.  Point of care diagnostics for sexually transmitted infections: perspectives and advances.

Authors:  Charlotte Gaydos; Justin Hardick
Journal:  Expert Rev Anti Infect Ther       Date:  2014-02-03       Impact factor: 5.091

5.  Point-of-care testing for chlamydia and gonorrhoea: implications for clinical practice.

Authors:  Lisa Natoli; Lisa Maher; Mark Shephard; Belinda Hengel; Annie Tangey; Steven G Badman; James Ward; Rebecca J Guy
Journal:  PLoS One       Date:  2014-06-23       Impact factor: 3.240

Review 6.  A Narrative Review of Where We Are With Point-of-Care Sexually Transmitted Infection Testing in the United States.

Authors:  Charlotte A Gaydos; Yukari C Manabe; Johan H Melendez
Journal:  Sex Transm Dis       Date:  2021-08-01       Impact factor: 2.830

7.  An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England.

Authors:  Katherine M E Turner; Jeff Round; Patrick Horner; John Macleod; Simon Goldenberg; Arminder Deol; Elisabeth J Adams
Journal:  Sex Transm Infect       Date:  2013-11-22       Impact factor: 3.519

8.  A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the "TTANGO" trial protocol.

Authors:  Rebecca J Guy; Lisa Natoli; James Ward; Louise Causer; Belinda Hengel; David Whiley; Sepehr N Tabrizi; Basil Donovan; Christopher K Fairley; Steven B Badman; Annie Tangey; Handan Wand; Mark Shephard; David G Regan; David Wilson; David Anderson; John M Kaldor
Journal:  BMC Infect Dis       Date:  2013-10-18       Impact factor: 3.090

9.  Mapping patient pathways and estimating resource use for point of care versus standard testing and treatment of chlamydia and gonorrhoea in genitourinary medicine clinics in the UK.

Authors:  Elisabeth J Adams; Alice Ehrlich; Katherine M E Turner; Kunj Shah; John Macleod; Simon Goldenberg; Robin K Meray; Vikki Pearce; Patrick Horner
Journal:  BMJ Open       Date:  2014-07-23       Impact factor: 2.692

Review 10.  A Systematic Review of Point of Care Testing for Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis.

Authors:  Sasha Herbst de Cortina; Claire C Bristow; Dvora Joseph Davey; Jeffrey D Klausner
Journal:  Infect Dis Obstet Gynecol       Date:  2016-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.